Edition:
United Kingdom

Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Global Select Market

2.37USD
23 Feb 2018
Change (% chg)

$0.01 (+0.42%)
Prev Close
$2.36
Open
$2.36
Day's High
$2.38
Day's Low
$2.34
Volume
129,068
Avg. Vol
235,164
52-wk High
$3.93
52-wk Low
$2.20

Select another date:

Fri, Nov 17 2017

BRIEF-Celldex Therapeutics initiates phase 2 combination study of CDX-3379 and Cetuximab in head and neck squamous cell Carcinoma

* Celldex Therapeutics Inc initiates phase 2 combination study of CDX-3379 and Cetuximab in head and neck squamous cell Carcinoma Source text for Eikon: Further company coverage:

BRIEF-Celldex Therapeutics Q3 loss per share $0.20

* Q3 earnings per share view $-0.27 -- Thomson Reuters I/B/E/S

Select another date: